Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

550
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
550
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

11
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
11
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

11
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
11
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

1.7K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
1.7K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

20
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
20

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reactive arthritis: the convoluted history of Reiter's disease.

Inflammopharmacology·2023
Same author

Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseases.

Inflammopharmacology·2023
Same author

John Alexander Mullin (1835-1899): The Canadian Physician who first described Osler's Nodes.

Inflammopharmacology·2023
Same author

Medical aspects of the tour by Martin Martin (c 1660-1719) of the Western and Northern Islands of Scotland, Circa 1695.

Inflammopharmacology·2023
Same author

The illness of William Soutar (1898-1943).

Inflammopharmacology·2023
Same author

Spondyloarthropathies and arthritis post-infection: a historical perspective.

Inflammopharmacology·2023
Same journal

Agomelatine for Sjögren's syndrome: a study on its therapeutic effects and mechanisms.

Inflammopharmacology·2026
Same journal

Neuropathic pain in traumatic brain injury: consequences, mechanisms, and therapeutic avenues.

Inflammopharmacology·2026
Same journal

REJENERA<sup>©</sup>, a multi-component bioflavonoid-based formula, alleviates osteoarthritis and provides chondroprotection by regulating the NLRP3-TXNIP-iNOS axis and inflammation: a comparative study with olive leaf nutraceuticals and ibuprofen.

Inflammopharmacology·2026
Same journal

Therapeutic evaluation of myricetin in experimental arthritis: modulation of inflammatory signaling and oxidative stress pathways.

Inflammopharmacology·2026
Same journal

Cortistatin as a pleiotropic regulator of neuroimmune and inflammatory pathways in experimental disease: a scoping review of preclinical evidence.

Inflammopharmacology·2026
Same journal

Clemastine ameliorates ulcerative colitis-induced cognitive impairment by restoring PI3K/Akt/GSK-3β signaling and suppressing ferroptosis.

Inflammopharmacology·2026
See all related articles

Related Experiment Video

Updated: Jul 30, 2025

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

2.5K

Sjögren's syndrome.

Geza Balint1, W Watson Buchanan2, Colin A Kean3

  • 13rd Department of Rheumatology, National Institute of Rheumatology and Physiotherapy, Frankel Leó út 27-29, Budapest, 1023, Hungary.

Inflammopharmacology
|May 17, 2023
PubMed
Summary
This summary is machine-generated.

Sjögren's syndrome causes dry eyes and dry mouth. This autoimmune condition can be primary or secondary, linked to other diseases like rheumatoid arthritis or infections such as hepatitis C.

Keywords:
Connective tissue diseaseDry eyesDry mouthKeratoconjunctivitis siccaSalivary gland enlargementXerostomia

More Related Videos

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
05:26

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

Published on: March 1, 2024

1.1K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

501

Related Experiment Videos

Last Updated: Jul 30, 2025

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

2.5K
Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
05:26

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

Published on: March 1, 2024

1.1K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

501

Area of Science:

  • Autoimmune diseases
  • Rheumatology
  • Immunology

Background:

  • Sjögren's syndrome (SS) is an autoimmune disorder.
  • Primary SS presents with dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia), often with salivary gland enlargement.
  • Secondary SS occurs alongside other connective tissue diseases (e.g., rheumatoid arthritis, lupus) or conditions like HIV, hepatitis C, and fibromyalgia.

Purpose of the Study:

  • To define the characteristics and associations of Sjögren's syndrome.

Main Methods:

  • Literature review and synthesis of existing data on Sjögren's syndrome.
  • Classification of primary and secondary Sjögren's syndrome.
  • Identification of associated conditions and diseases.

Main Results:

  • Sjögren's syndrome is characterized by specific symptoms like dry eyes and dry mouth.
  • Primary SS is defined by these core symptoms.
  • Secondary SS is identified when co-occurring with other autoimmune or chronic conditions.

Conclusions:

  • Sjögren's syndrome encompasses a range of clinical presentations.
  • Understanding the primary and secondary forms aids in diagnosis and management.
  • SS is linked to a diverse spectrum of systemic diseases and infections.